from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3405c/-

LFCtreatmentdescriptionclass of inhibitor

0.862

Amikacinug/mL Amikacintranslation

0.625

Cap5-10ug/mL Capreomycintranslation

1.941

Rox10-50 ug/mL Roxithromycintranslation

0.780

SM2-5 ug/mL Streptomycintranslation

0.845

Tet5-10 ug/mL Tetracyclinetranslation

-0.224

Rif0.2-5ug/mL Rifampicintranscription

0.008

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.615

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.210

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-1.128

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.213

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.526

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.218

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.880

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.925

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.038

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.691

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.136

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.477

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.670

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.250

KCN5-20 ug/mL Potassium cyaniderespiration

-0.615

NaN30.2-2 mM Sodium aziderespiration

-0.501

Nigericin50 uM Nigericinrespiration

0.163

TRC10-150 ug/mL Triclosanrespiration

1.632

TRZ10-25 ug/mL Thioridazinerespiration

2.618

Valinomycin0.5-10 uM Valinomycinrespiration

-1.575

ZnSO42 mM ZnSO4respiration

-0.658

menadione6-10 ug/mL Menadionerespiration

0.226

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.271

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.899

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.035

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.708

NRP_1Non-replicating persistence stage 1dosRassociated

0.062

Amp0.2mg/mL AmpicillincellWall

0.342

Cephalexin20-100 ug/mL CephalexincellWall

0.159

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.025

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.331

EMB10-20 ug/mL EthambutolcellWall

-0.030

Eta12-40 ug/mL EthionamidecellWall

0.297

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.100

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.047

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.202

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.067

BZA0.12 mg/mL BenzamidearomaticAmides

-0.252

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.154

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.101

H2O24 mM hydrogen peroxideDNAdamaging

0.237

Levo10 ug/mL LevofloxacinDNAdamaging

-0.266

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.249

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.365

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.086

UVUV-irradiationDNAdamaging

0.128

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.221

Antimycin12.5-50 ug/mL Antimycin A?

0.271

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.523

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.079

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.947

PA8240.2-2 ug/mL PA-824?

-0.659

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.015

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.211

Verapamil50 uM Verapamil?

0.264

mercaptoethanol2 mM 2-Mercaptoethanol?

0.731

methoxatin10-20 ug/mL Methoxatin?